(Total Views: 233)
Posted On: 09/13/2019 3:20:43 PM
Post# of 103534
$AMGN News Article - Amgen Announces Phase 3 CANDOR Study Combining KYPROLIS (carfilzomib) And DARZALEX (daratumumab) Meets Primary Endpoint Of Progression-Free Survival https://marketwirenews.com/news-releases/amge...87700.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
